BIRC5 and ovarian neoplasm: A previous study found that miR-203 inhibits ovarian tumor metastasis by targeting BIRC5/survivin and that BIRC5/survivin can also serve as a target for glycolysis inhibition in high-stage neuroblastoma [56].